Remnant cholesterol in patients admitted for acute coronary syndromes

被引:24
作者
Cordero, Alberto [1 ,2 ,3 ]
Alvarez-Alvarez, Belen [3 ,4 ]
Escribano, David [1 ,2 ]
Garcia-Acuna, Jose Ma [3 ,4 ]
Cid-Alvarez, Belen [3 ,4 ]
Rodriguez-Manero, Moises [3 ,4 ]
Amparo Quintanilla, M. [1 ,2 ]
Agra-Bermejo, Rosa [3 ,4 ]
Zuazola, Pilar [1 ]
Gonzalez-Juanatey, Jose R. [3 ,4 ]
机构
[1] Hosp Univ San Juan, Cardiol Dept, Carretera Valencia Alicante Sn, Alacant, Spain
[2] Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Unidad Invest Cardiol, Valencia, Spain
[3] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
[4] Complejo Hosp Univ Santiago, Cardiol Dept, Rua Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
关键词
Cholesterol; Remnant; Acute coronary syndrome; Mortality; Heart failure; DENSITY-LIPOPROTEIN CHOLESTEROL; MYOCARDIAL-INFARCTION; HEART-DISEASE; TRIGLYCERIDES; OUTCOMES; RISK; MORTALITY; INSIGHTS; THERAPY; STROKE;
D O I
10.1093/eurjpc/zwac286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lay summary Elevated remnant cholesterol is highly prevalent in patients admitted for ACS and is related to body mass index and negatively with age. Remnant cholesterol it is not associated to higher in-hospital mortality risk, but it confers higher long-term risk of mortality and heart failure. Background Remnant cholesterol has been identified as one of leading lipid values associated with the incidence of coronary heart disease. There is scarce evidence on its distribution and prognostic value in acute coronary syndrome (ACS) patients. Methods and results We included all consecutive patients admitted for ACS in two different centres. Remnant cholesterol was calculated by the equation: total cholesterol minus LDL cholesterol minus HDL cholesterol, and values >= 30 were considered high. Among the 7479 patients, median remnant cholesterol level was 28 mg/dL (21-39), and 3429 (45.85%) patients had levels >= 30 mg/dL. Age (r: -0.29) and body mass index (r: 0.44) were the variables more strongly correlated. At any given age, patients with overweigh or obesity had higher levels. In-hospital mortality was 3.75% (280 patients). Remnant cholesterol was not associated to higher in-hospital mortality risk (odds ratio: 0.89; P = 0.21). After discharge (median follow-up of 57 months), an independent and linear risk of all-cause mortality and heart failure (HF) associated to cholesterol remnant levels was observed. Remnant cholesterol levels >60 mg/dL were associated to higher risk of mortality [hazard ratio (HR): 1.49 95% CI 1.08-2.06; P = 0.016], cardiovascular mortality (HR: 1.49 95% CI 1.08-2.06; P = 0.016), and HF re-admission (sub-HR: 1.55 95% CI 1.14-2.11; P = 0.005). Conclusions Elevated remnant cholesterol is highly prevalent in patients admitted for ACS and is inversely correlated with age and positively with body mass index. Remnant cholesterol levels were not associated to higher in-hospital mortality risk, but they were associated with higher long-term risk of mortality and HF.
引用
收藏
页码:340 / 348
页数:9
相关论文
共 36 条
[1]   The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease [J].
Bornfeldt, Karin E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (07) :819-830
[2]   Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease [J].
Castaner, Olga ;
Pinto, Xavier ;
Subirana, Isaac ;
Amor, Antonio J. ;
Ros, Emilio ;
Hernaez, Alvaro ;
Angel Martinez-Gonzalez, Miguel ;
Corella, Dolores ;
Salas-Salvado, Jordi ;
Estruch, Ramon ;
Lapetra, Jose ;
Gomez-Gracia, Enrique ;
Alonso-Gomez, Angel M. ;
Fiol, Miquel ;
Serra-Majem, Lluis ;
Corbella, Emili ;
Benaiges, David ;
Sorli, Jose V. ;
Ruiz-Canela, Miguel ;
Babio, Nancy ;
Sierra, Lucas Tojal ;
Ortega, Emilio ;
Fito, Montserrat .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) :2712-2724
[3]   Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry [J].
Cordero, Alberto ;
Fernandez Olmo, M. Rosa ;
Cortez Quiroga, Gustavo A. ;
Romero-Menor, Cesar ;
Facila, Lorenzo ;
Seijas-Amigo, Jose ;
Rondan Murillo, Juan ;
Sandin, Miriam ;
Rodriguez-Manero, Moises ;
Bello Mora, Maria C. ;
Valle, Alfonso ;
Fornovi, Aisa ;
Freixa Pamias, Roman ;
Baneras, Jordi ;
Blanch Garcia, Pedro ;
Clemente Lorenzo, Maria Milagros ;
Sanchez-Alvarez, Sergio ;
Lopez-Rodriguez, Luis ;
Gonzalez-Juanatey, Jose R. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (12)
[4]  
Cordero A, 2021, REV ESP CARDIOL, V74, P494, DOI [10.1016/j.rec.2020.03.011, 10.1016/j.recesp.2020.03.020]
[5]   Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)" [J].
Cordero, Alberto ;
Bertomeu-Gonzalez, Vicente ;
Rodriguez-Manero, Moises .
CIRCULATION, 2018, 137 (24) :2658-2659
[6]  
Cordero A, 2012, REV ESP CARDIOL, V65, P319, DOI [10.1016/j.rec.2011.09.003, 10.1016/j.recesp.2011.07.022]
[7]   Usefulness of Triglycerides-to-High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men [J].
Cordero, Alberto ;
Andres, Eva ;
Ordonez, Beatriz ;
Leon, Montserrat ;
Laclaustra, Martin ;
Grima, Alberto ;
Luengo, Emilio ;
Moreno, Jose ;
Bes, Maria ;
Pascual, Isaac ;
Civeira, Fernando ;
Pocovi, Miguel ;
Alegria, Eduardo ;
Casasnovas, Jose A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (10) :1393-1397
[8]   Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction [J].
Doi, Takahito ;
Langsted, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (24) :2383-2397
[9]   Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease [J].
Elshazly, Mohamed B. ;
Mani, Preethi ;
Nissen, Steven ;
Brennan, Danielle M. ;
Clark, Donald, III ;
Martin, Seth ;
Jones, Steven R. ;
Quispe, Renato ;
Donnellan, Eoin ;
Nicholls, Stephen J. ;
Puri, Rishi .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (10) :1091-1100
[10]  
Facila L., 2012, REV ESP CARDIOL, V1, P66